NDBT
PFE icon

North Dallas Bank & Trust’s Pfizer PFE Stock Holding History

North Dallas Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
14,648
-600
-4% -$15.7K 0.21% 94
2026
Q1 		$428K Sell
15,248
-400
-3% -$10.6K 0.29% 79
2025
Q4 		$390K Buy
+15,648
New +$395K 0.25% 83
2025
Q2 		$388K Buy
+16,004
New +$373K 0.29% 78

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

North Dallas Bank & Trust's PFE Position: Q2 2026 in Review

North Dallas Bank & Trust reduced its Pfizer (PFE) stake by 3.9% in Q2 2026, selling an estimated $15.7K and leaving 14,648 shares worth $353K. The position accounts for 0.21% of the portfolio, ranked #94.

North Dallas Bank & Trust first reported a position in PFE in Q2 2025 and has held it in 4 quarters since. The position peaked at $428K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • North Dallas Bank & Trust held 14,648 shares of Pfizer worth $353K as of Q2 2026.
  • North Dallas Bank & Trust sold 600 Pfizer shares in Q2 2026, an estimated $15.7K.
  • Pfizer made up 0.21% of North Dallas Bank & Trust's portfolio in Q2 2026, its #94 holding.
  • North Dallas Bank & Trust first reported a position in Pfizer in Q2 2025 and has held it in 4 quarters since.
  • North Dallas Bank & Trust's Pfizer position peaked at $428K in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on North Dallas Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.